BACE2 expression increases in human neurodegenerative disease

American Journal of Pathology

Volumn 180, Issue 1, 2012, Pages 337-350

  Holler, Christopher J ^a   Webb, Robin L ^a   Laux, Ashley L ^a   Beckett, Tina L ^a   Niedowicz, Dana M ^a   Ahmed, Rachel R ^a   Liu, Yinxing ^a   Simmons, Christopher R ^a   Dowling, Amy L S ^a,b   Spinelli, Angela ^c   Khurgel, Moshe ^c   Estus, Steven ^a   Head, Elizabeth ^a,b   Hersh, Louis B ^a   Murphy, M Paul ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c BRIDGEWATER COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE 1; BETA SECRETASE 2;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE SEVERITY; DOWN SYNDROME; ENZYME ACTIVITY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; BRAIN CHEMISTRY; FEMALE; HUMANS; MALE; NEPRILYSIN; NEURONS; RNA, MESSENGER;

EID: 83455164148     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.09.034     Document Type: Article

References (79)

1. X. Cao, T.C. Sudhof A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60 Science 293 2001 115 120 (Pubitemid 32625507)
2. A. Capell, L. Meyn, R. Fluhrer, D.B. Teplow, J. Walter, C. Haass Apical sorting of β-secretase limits amyloid β-peptide production J Biol Chem 277 2002 5637 5643 (Pubitemid 34968618)
3. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers, M. Citron β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 1999 735 741
4. A. Capell, H. Steiner, M. Willem, H. Kaiser, C. Meyer, J. Walter, S. Lammich, G. Multhaup, C. Haass Maturation and pro-peptide cleavage of β-secretase J Biol Chem 275 2000 30849 30854
5. M. Willem, A.N. Garratt, B. Novak, M. Citron, S. Kaufmann, A. Rittger, B. DeStrooper, P. Saftig, C. Birchmeier, C. Haass Control of peripheral nerve myelination by the β-secretase BACE1 Science 314 2006 664 666 (Pubitemid 44646394)
6. D.J. Loane, A. Pocivavsek, C.E. Moussa, R. Thompson, Y. Matsuoka, A.I. Faden, G.W. Rebeck, M.P. Burns Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury Nat Med 15 2009 377 379
7. H. Li, B. Wang, Z. Wang, Q. Guo, K. Tabuchi, R.E. Hammer, T.C. Sudhof, H. Zheng Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP Proc Natl Acad Sci U S A 107 2010 17362 17367
8. O. Zohar, S. Cavallaro, V. D'Agata, D.L. Alkon Quantification and distribution of β-secretase alternative splice variants in the rat and human brain Brain Res Mol Brain Res 115 2003 63 68 (Pubitemid 36725036)
9. I. Hussain, D.J. Powell, D.R. Howlett, G.A. Chapman, L. Gilmour, P.R. Murdock, D.G. Tew, T.D. Meek, C. Chapman, K. Schneider, S.J. Ratcliffe, D. Tattersall, T.T. Testa, C. Southan, D.M. Ryan, D.L. Simmons, F.S. Walsh, C. Dingwall, G. Christie ASP1 (BACE2) cleaves the amyloid precursor protein at the β-secretase site Mol Cell Neurosci 16 2000 609 619 (Pubitemid 32001309)
10. G. Basi, N. Frigon, R. Barbour, T. Doan, G. Gordon, L. McConlogue, S. Sinha, M. Zeller Antagonistic effects of β-site amyloid precursor protein-cleaving enzymes 1 and 2 on β-amyloid peptide production in cells J Biol Chem 278 2003 31512 31520 (Pubitemid 37048328)
11. B.D. Bennett, S. Babu-Khan, R. Loeloff, J.C. Louis, E. Curran, M. Citron, R. Vassar Expression analysis of BACE2 in brain and peripheral tissues J Biol Chem 275 2000 20647 20651 (Pubitemid 30457651)
12. B. Maloney, Y.W. Ge, N.H. Greig, D.K. Lahiri Characterization of the human β-secretase 2 (BACE2) 5′-flanking region: identification of a 268-bp region as the basal BACE2 promoter J Mol Neurosci 29 2006 81 99 (Pubitemid 43853045)
13. F. Acquati, M. Accarino, C. Nucci, P. Fumagalli, L. Jovine, S. Ottolenghi, R. Taramelli The gene encoding DRAP (BACE2), a glycosylated transmembrane protein of the aspartic protease family, maps to the down critical region FEBS Lett 468 2000 59 64 (Pubitemid 30101682)
14. K. Motonaga, M. Itoh, L.E. Becker, Y. Goto, S. Takashima Elevated expression of β-site amyloid precursor protein cleaving enzyme 2 in brains of patients with Down syndrome Neurosci Lett 326 2002 64 66 (Pubitemid 34607595)
15. Y. Luo, B. Bolon, S. Kahn, B.D. Bennett, S. Babu-Khan, P. Denis, W. Fan, H. Kha, J. Zhang, Y. Gong, L. Martin, J.-C. Louis, Q. Yan, W.G. Richards, M. Citron, R. Vassar Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation Nature neuroscience 4 2001 231 232 (Pubitemid 32194866)
16. M. Ohno, S.L. Cole, M. Yasvoina, J. Zhao, M. Citron, R. Berry, J.F. Disterhoft, R. Vassar BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice Neurobiol Dis 26 2007 134 145 (Pubitemid 46436493)
17. X. Hu, X. Zhou, W. He, J. Yang, W. Xiong, P. Wong, C.G. Wilson, R. Yan BACE1 deficiency causes altered neuronal activity and neurodegeneration J Neurosci 30 2010 8819 8829
18. A.V. Savonenko, T. Melnikova, F.M. Laird, K.A. Stewart, D.L. Price, P.C. Wong Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice Proc Natl Acad Sci U S A 105 2008 5585 5590 (Pubitemid 351753906)
19. H. Cai, Y. Wang, D. McCarthy, H. Wen, D.R. Borchelt, D.L. Price, P.C. Wong BACE1 is the major β-secretase for generation of Aβ peptides by neurons Nature neuroscience 4 2001 233 234 (Pubitemid 32194867)
20. D. Dominguez, J. Tournoy, D. Hartmann, T. Huth, K. Cryns, S. Deforce, L. Serneels, I.E. Camacho, E. Marjaux, K. Craessaerts, A.J. Roebroek, M. Schwake, R. D'Hooge, P. Bach, U. Kalinke, D. Moechars, C. Alzheimer, K. Reiss, P. Saftig, B. De Strooper Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice J Biol Chem 280 2005 30797 30806 (Pubitemid 41291810)
21. R. Li, K. Lindholm, L.B. Yang, X. Yue, M. Citron, R. Yan, T. Beach, L. Sue, M. Sabbagh, H. Cai, P. Wong, D. Price, Y. Shen Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients Proc Natl Acad Sci U S A 101 2004 3632 3637 (Pubitemid 38338246)
22. R.R. Ahmed, C.J. Holler, R.L. Webb, F. Li, T.L. Beckett, M.P. Murphy BACE1 and BACE2 enzymatic activities in Alzheimer's disease J Neurochem 112 2010 1045 1053
23. H. Fukumoto, B.S. Cheung, B.T. Hyman, M.C. Irizarry β-secretase protein and activity are increased in the neocortex in Alzheimer disease Arch Neurol 59 2002 1381 1389 (Pubitemid 35014802)
24. R.M. Holsinger, C.A. McLean, K. Beyreuther, C.L. Masters, G. Evin Increased expression of the amyloid precursor β-secretase in Alzheimer's disease Ann Neurol 51 2002 783 786 (Pubitemid 34568861)
25. L.B. Yang, K. Lindholm, R. Yan, M. Citron, W. Xia, X.L. Yang, T. Beach, L. Sue, P. Wong, D. Price, R. Li, Y. Shen Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease Nat Med 9 2003 3 4 (Pubitemid 36098241)
26. R.M. Holsinger, J.S. Lee, A. Boyd, C.L. Masters, S.J. Collins CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias Neurology 67 2006 710 712 (Pubitemid 44273629)
27. H. Zetterberg, U. Andreasson, O. Hansson, G. Wu, S. Sankaranarayanan, M.E. Andersson, P. Buchhave, E. Londos, R.M. Umek, L. Minthon, A.J. Simon, K. Blennow Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease Arch Neurol 65 2008 1102 1107
28. W.W. Liu, S. Todd, D. Craig, A.P. Passmore, D.T. Coulson, S. Murphy, G.B. Irvine, J.A. Johnston Elevated platelet β-secretase activity in mild cognitive impairment Dement Geriatr Cogn Disord 24 2007 464 468 (Pubitemid 350175907)
29. J.L. Price, D.W. McKeel Jr, V.D. Buckles, C.M. Roe, C. Xiong, M. Grundman, L.A. Hansen, R.C. Petersen, J.E. Parisi, D.W. Dickson, C.D. Smith, D.G. Davis, F.A. Schmitt, W.R. Markesbery, J. Kaye, R. Kurlan, C. Hulette, B.F. Kurland, R. Higdon, W. Kukull, J.C. Morris Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease Neurobiol Aging 30 2009 1026 1036
30. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308 (Pubitemid 29120227)
31. N.J. Cairns, E.H. Bigio, I.R. Mackenzie, M. Neumann, V.M. Lee, K.J. Hatanpaa, C.L. White CL III, J.A. Schneider, L.T. Grinberg, G. Halliday, C. Duyckaerts, J.S. Lowe, I.E. Holm, M. Tolnay, K. Okamoto, H. Yokoo, S. Murayama, J. Woulfe, D.G. Munoz, D.W. Dickson, P.G. Ince, J.Q. Trojanowski, D.M. Mann Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Acta Neuropathol 114 2007 5 22 (Pubitemid 47029055)
32. F.A. Schmitt, D.G. Davis, D.R. Wekstein, C.D. Smith, J.W. Ashford, W.R. Markesbery "Preclinical" AD revisited: neuropathology of cognitively normal older adults Neurology 55 2000 370 376 (Pubitemid 30654797)
33. P.T. Nelson, E.L. Abner, F.A. Schmitt, R.J. Kryscio, G.A. Jicha, C.D. Smith, D.G. Davis, J.W. Poduska, E. Patel, M.S. Mendiondo, W.R. Markesbery Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons Brain Pathol 20 2010 66 79
34. T.L. Beckett, D.M. Niedowicz, C.M. Studzinski, A.M. Weidner, R.L. Webb, C.J. Holler, R.R. Ahmed, H. LeVine III, M.P. Murphy Effects of nonsteroidal anti-inflammatory drugs on amyloid-β pathology in mouse skeletal muscle Neurobiol Dis 39 2010 449 456
35. H. Fukumoto, D.L. Rosene, M.B. Moss, S. Raju, B.T. Hyman, M.C. Irizarry β-Secretase activity increases with aging in human, monkey, and mouse brain Am J Pathol 164 2004 719 725 (Pubitemid 38364685)
36. H. Shinall, E.S. Song, L.B. Hersh Susceptibility of amyloid β peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral Biochemistry 44 2005 15345 15350 (Pubitemid 41681468)
37. S. De Lombaert, M.D. Erion, J. Tan, L. Blanchard, L. el-Chehabi, R.D. Ghai, Y. Sakane, C. Berry, A.J. Trapani N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors J Med Chem 37 1994 498 511 (Pubitemid 24094831)
38. E. McGowan, F. Pickford, J. Kim, L. Onstead, J. Eriksen, C. Yu, L. Skipper, M.P. Murphy, J. Beard, P. Das, K. Jansen, M. Delucia, W.L. Lin, G. Dolios, R. Wang, C.B. Eckman, D.W. Dickson, M. Hutton, J. Hardy, T. Golde Aβ42 is essential for parenchymal and vascular amyloid deposition in mice Neuron 47 2005 191 199 (Pubitemid 41019251)
39. E. Head, V. Pop, F. Sarsoza, R. Kayed, T.L. Beckett, C.M. Studzinski, J.L. Tomic, C.G. Glabe, M.P. Murphy Amyloid-β peptide and oligomers in the brain and cerebrospinal fluid of aged canines J Alzheimers Dis 20 2010 637 646
40. I.F. Ling, S. Estus Role of SFRS13A in low-density lipoprotein receptor splicing Hum Mutat 31 2010 702 709
41. C.A. Lemere, J.K. Blusztajn, H. Yamaguchi, T. Wisniewski, T.C. Saido, D.J. Selkoe Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation Neurobiol Dis 3 1996 16 32
42. J. Zhao, Y. Fu, M. Yasvoina, P. Shao, B. Hitt, T. O'Connor, S. Logan, E. Maus, M. Citron, R. Berry, L. Binder, R. Vassar β-Site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis J Neurosci 27 2007 3639 3649 (Pubitemid 46557686)
43. T. O'Connor, K.R. Sadleir, E. Maus, R.A. Velliquette, J. Zhao, S.L. Cole, W.A. Eimer, B. Hitt, L.A. Bembinster, S. Lammich, S.F. Lichtenthaler, S.S. Hebert, B. De Strooper, C. Haass, D.A. Bennett, R. Vassar Phosphorylation of the translation initiation factor eIF2α increases BACE1 levels and promotes amyloidogenesis Neuron 60 2008 988 1009
44. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N.P. Gerard, C. Gerard, E. Hama, H.J. Lee, T.C. Saido Metabolic regulation of brain Aβ by neprilysin Science 292 2001 1550 1552
45. J.H. Stockley, R. Ravid, C. O'Neill Altered β-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain FEBS Lett 580 2006 6550 6560 (Pubitemid 44827012)
46. G.G. Westmeyer, M. Willem, S.F. Lichtenthaler, G. Lurman, G. Multhaup, I. Assfalg-Machleidt, K. Reiss, P. Saftig, C. Haass Dimerization of β-site β-amyloid precursor protein-cleaving enzyme J Biol Chem 279 2004 53205 53212 (Pubitemid 40051823)
47. M.S. Cheon, M. Dierssen, S.H. Kim, G. Lubec Protein expression of BACE1: BACE2 and APP in Down syndrome brains Amino Acids 35 2008 339 343
48. L. Barbiero, L. Benussi, R. Ghidoni, A. Alberici, C. Russo, G. Schettini, S.F. Pagano, E.A. Parati, F. Mazzoli, F. Nicosia, S. Signorini, E. Feudatari, G. Binetti BACE-2 is overexpressed in Down's syndrome Exp Neurol 182 2003 335 345 (Pubitemid 36937086)
49. X. Sun, G. He, W. Song BACE2, as a novel APP θ-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome FASEB J 20 2006 1369 1376 (Pubitemid 44943845)
50. M. Nistor, M. Don, M. Parekh, F. Sarsoza, M. Goodus, G.E. Lopez, C. Kawas, J. Leverenz, E. Doran, I.T. Lott, M. Hill, E. Head α- and β-secretase activity as a function of age and β-amyloid in Down syndrome and normal brain Neurobiol Aging 28 2007 1493 1506 (Pubitemid 47238529)
51. Y. Jiang, K.A. Mullaney, C.M. Peterhoff, S. Che, S.D. Schmidt, A. Boyer-Boiteau, S.D. Ginsberg, A.M. Cataldo, P.M. Mathews, R.A. Nixon Alzheimer's-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition Proc Natl Acad Sci U S A 107 2010 1630 1635
52. K. Yasojima, E.G. McGeer, P.L. McGeer Relationship between β amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain Brain Res 919 2001 115 121 (Pubitemid 33016594)
53. D.T. Coulson, N. Beyer, J.G. Quinn, S. Brockbank, J. Hellemans, G.B. Irvine, R. Ravid, J.A. Johnston BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue J Alzheimers Dis 22 2010 1111 1122
54. O. Zohar, C.G. Pick, S. Cavallaro, J. Chapman, A. Katzav, A. Milman, D.L. Alkon Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice Neurobiol Aging 26 2005 1167 1175 (Pubitemid 40726009)
55. B. Bettegazzi, M. Mihailovich, A. Di Cesare, A. Consonni, R. Macco, I. Pelizzoni, F. Codazzi, F. Grohovaz, D. Zacchetti β-Secretase activity in rat astrocytes: translational block of BACE1 and modulation of BACE2 expression Eur J Neurosci 33 2011 236 243
56. J.T. Coyle, M.L. Oster-Granite, J.D. Gearhart The neurobiologic consequences of Down syndrome Brain Res Bull 16 1986 773 787 (Pubitemid 16041613)
57. Y. Wen, W.H. Yu, B. Maloney, J. Bailey, J. Ma, I. Marie, T. Maurin, L. Wang, H. Figueroa, M. Herman, P. Krishnamurthy, L. Liu, E. Planel, L.F. Lau, D.K. Lahiri, K. Duff Transcriptional regulation of β-secretase by p25/cdk5 leads to enhanced amyloidogenic processing Neuron 57 2008 680 690 (Pubitemid 351335351)
58. E. Tamagno, M. Guglielmotto, L. Giliberto, A. Vitali, R. Borghi, R. Autelli, O. Danni, M. Tabaton JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1 Neurobiol Aging 30 2009 1563 1573
59. S. Lammich, S. Schobel, A.K. Zimmer, S.F. Lichtenthaler, C. Haass Expression of the Alzheimer protease BACE1 is suppressed via its 5′-untranslated region EMBO Rep 5 2004 620 625 (Pubitemid 39139534)
60. W.X. Wang, B.W. Rajeev, A.J. Stromberg, N. Ren, G. Tang, Q. Huang, I. Rigoutsos, P.T. Nelson The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1 J Neurosci 28 2008 1213 1223 (Pubitemid 351186356)
61. S.S. Hebert, K. Horre, L. Nicolai, A.S. Papadopoulou, W. Mandemakers, A.N. Silahtaroglu, S. Kauppinen, A. Delacourte, B. De Strooper Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression Proc Natl Acad Sci U S A 105 2008 6415 6420 (Pubitemid 351758360)
62. M.A. Faghihi, F. Modarresi, A.M. Khalil, D.E. Wood, B.G. Sahagan, T.E. Morgan, C.E. Finch, G. St Laurent III, P.J. Kenny, C. Wahlestedt Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase Nat Med 14 2008 723 730
63. X. Sun, Y. Wang, H. Qing, M.A. Christensen, Y. Liu, W. Zhou, Y. Tong, C. Xiao, Y. Huang, S. Zhang, X. Liu, W. Song Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes FASEB J 19 2005 739 749 (Pubitemid 40617378)
64. R. Dosunmu, J. Wu, L. Adwan, B. Maloney, M.R. Basha, C.A. McPherson, G.J. Harry, D.C. Rice, N.H. Zawia, D.K. Lahiri Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice J Alzheimers Dis 18 2009 211 230
65. B.A. Citron, J.S. Dennis, R.S. Zeitlin, V. Echeverria Transcription factor Sp1 dysregulation in Alzheimer's disease J Neurosci Res 86 2008 2499 2504
66. K. Sambamurti, R. Kinsey, B. Maloney, Y.W. Ge, D.K. Lahiri Gene structure and organization of the human β-secretase (BACE) promoter FASEB J 18 2004 1034 1036 (Pubitemid 39561516)
67. D.K. Lahiri, B. Maloney, Y.W. Ge Functional domains of the BACE1 and BACE2 promoters and mechanisms of transcriptional suppression of the BACE2 promoter in normal neuronal cells J Mol Neurosci 29 2006 65 80 (Pubitemid 43853044)
68. K. Liu, I. Solano, D. Mann, C. Lemere, M. Mercken, J.Q. Trojanowski, V.M. Lee Characterization of Aβ1140/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Aβ species in the pathogenesis of Alzheimer's disease Acta Neuropathol 112 2006 163 174
69. K.G. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, J.C. Morris, K.E. Yarasheski, R.J. Bateman Decreased clearance of CNS β-amyloid in Alzheimer's disease Science 330 2010 1774
70. S.M. Huang, A. Mouri, H. Kokubo, R. Nakajima, T. Suemoto, M. Higuchi, M. Staufenbiel, Y. Noda, H. Yamaguchi, T. Nabeshima, T.C. Saido, N. Iwata Neprilysin-sensitive synapse-associated amyloid-β peptide oligomers impair neuronal plasticity and cognitive function J Biol Chem 281 2006 17941 17951 (Pubitemid 44035593)
71. A. Caccamo, S. Oddo, M.C. Sugarman, Y. Akbari, F.M. LaFerla Age- and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders Neurobiol Aging 26 2005 645 654 (Pubitemid 40228756)
72. J.S. Miners, Z. Van Helmond, K. Chalmers, G. Wilcock, S. Love, P.G. Kehoe Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy J Neuropathol Exp Neurol 65 2006 1012 1021 (Pubitemid 44521802)
73. S. Wang, R. Wang, L. Chen, D.A. Bennett, D.W. Dickson, D.S. Wang Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain J Neurochem 115 2010 47 57
74. M. Maruyama, M. Higuchi, Y. Takaki, Y. Matsuba, H. Tanji, M. Nemoto, N. Tomita, T. Matsui, N. Iwata, H. Mizukami, S. Muramatsu, K. Ozawa, T.C. Saido, H. Arai, H. Sasaki Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease Ann Neurol 57 2005 832 842 (Pubitemid 40798621)
75. J.S. Miners, Z. van Helmond, P.G. Kehoe, S. Love Changes with age in the activities of β-secretase and the Aβ-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme Brain Pathol 20 2010 794 802
76. J.S. Miners, S. Morris, S. Love, P.G. Kehoe Accumulation of insoluble amyloid-β in Down's syndrome is associated with increased BACE-1 and neprilysin activities J Alzheimers Dis 23 2011 101 108
77. G. Azkona, D. Levannon, Y. Groner, M. Dierssen In vivo effects of APP are not exacerbated by BACE2 co-overexpression: behavioural characterization of a double transgenic mouse model Amino Acids 39 2010 1571 1580
78. E.B. Lee, B. Zhang, K. Liu, E.A. Greenbaum, R.W. Doms, J.Q. Trojanowski, V.M. Lee BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo J Cell Biol 168 2005 291 302 (Pubitemid 40248226)
79. E. Rockenstein, M. Mante, M. Alford, A. Adame, L. Crews, M. Hashimoto, L. Esposito, L. Mucke, E. Masliah High β-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-β levels: implications for the treatment of Alzheimer disease J Biol Chem 280 2005 32957 32967 (Pubitemid 41368345)